Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary?

摘要

Background Recent clinical practice guidelines recommend that routine screening of MEN1 mutation carriers should start at the age of 5 years. The occurrence of clinically relevant MEN1 organ manifestations in children ( <= 18 years) was evaluated.